Effect of Shenling Baizhu Powder on Tumor Markers and Immune Function in Postoperative Chemotherapy Patients with Colorectal Cancer

March 1, 2026Guangming Journal of Chinese Medicine

View at Publisher

Ask AI

Bookmark

Share

Key Points

This investigation aims to analyze the effect of Shenling Baizhu Powder on tumor markers and immune function in patients undergoing postoperative chemotherapy for colorectal cancer.
86 postoperative colorectal cancer patients receiving chemotherapy were randomly divided into two groups: control (XELOX) and observation (XELOX + Shenling Baizhu Powder).
Clinical efficacy, traditional Chinese medicine syndrome scores, tumor markers, quality of life, immune function, and adverse reactions were compared between groups.
Assessments were conducted post-treatment to evaluate the outcomes.
The clinical effective rate in the observation group was significantly higher than in the control group (P<0.05).
Traditional Chinese medicine syndrome scores and tumor marker levels were lower in the observation group, with Karnofsky scores higher than those in the control group (P<0.05).
CD4+, CD4+/CD8+ levels were higher and CD8+ levels were lower in the observation group compared to the control group (P<0.05); adverse reaction rates were also lower in the observation group (P<0.05).

Evaluates Shenling Baizhu Powder's impact on immune function and tumor markers in chemotherapy patients, suggesting improved outcomes.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Shuangyang MA (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share